Neurovalens were delighted to be awarded two recognitions at the 2024 Digital DNA awards in Belfast’s ICC, Waterfront on Thursday, March 21st. Small Tech Company of the Year and Highly Commended in the Tech For Good category.
Building a high-performance team requires high performance leadership. Our Chief Project Officer, Iain Hendrick, will be spending the next 12 months on the Shott Scale Up Accelerator program with the Royal Academy of Engineering.
Joining Neurovalens was a no-brainer for me! I loved the idea of working for a company that was trying to help people. I also had an interest in the brain for as long as I can remember...
My name is Sinead Watson, and I joined Neurovalens in September 2022. My role at Neurovalens is Head of Clinical & Regulatory that involves leading the clinical team in the planning, execution and delivery of several clinical trials and regulatory submissions.
Neurovalens were delighted to take our FDA Cleared Modius Sleep technology to Arab Health 2024, a Global Healthcare Medical Expo in Dubai from 29th January to 1st February 2024.
My name is Rachel Robinson and I joined Neurovalens in September 2022 as a Lead Clinical Researcher. From a young age I was always fascinated about the function and development of the human body and this is the main reason I chose to focus my studies within the fields of anatomy and physiology.
Neurovalens are an ISO 13485 certified medical device company.
This is an international standard that sets out regulatory requirements for medical device quality management systems.
CPO Iain Hendrick and Software QA Manager Steven George attended Medica 2023 in Düsseldorf, Germany to showcase the newly FDA cleared Modius Sleep headset.
I'm Steven George, but most people know me as Stevie. I've been at Neurovalens almost 6 years, it feels like no time since I joined yet so much has changed and so much has been achieved.
Neurovalens, a global leader in non-invasive neuro-technology, has received medical device clearance from the US Food & Drug Administration (FDA) to treat chronic insomnia with its Modius Sleep device.
My name is Erin, and I am a Clinical Trial Coordinator at Neurovalens. I joined the team in September 2020. I initially joined Neurovalens as a year-long placement student during my Pharmaceutical Biotechnology at Queen’s University Belfast.